[Urticaria associated with COVID-19 in allergic patients. A case series].

Q3 Medicine
Catalina López, Ricardo Cardona
{"title":"[Urticaria associated with COVID-19 in allergic patients. A case series].","authors":"Catalina López,&nbsp;Ricardo Cardona","doi":"10.29262/ram.v68i3.869","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>In December 2019, a new coronavirus was identified as the causal agent of the 2019 coronavirus disease (COVID-19) with a wide clinical spectrum that goes from asymptomatic cases to critical and fatal cases. Its usual manifestations are fever, cough, and fatigue; although some cases present skin lesions.</p><p><strong>Cases report: </strong>The first case was a 30-year-old woman with a history of controlled solar urticaria who presented erythematous and pruritic wheals in malar and cervical regions and extremities; associated with general malaise, headaches, and nausea, in whom the presence of COVID-19 was confirmed; her condition improved with a quadruple dose of antihistamines. The second case was a 47-year-old woman with a history of wasp sting anaphylaxis, without mastocytosis, who presented nasal congestion, headaches, and hypogeusia associated with generalized, erythematous, and pruritic wheals, with confirmation of COVID-19; her condition improved with quadruple doses of antihistamines.</p><p><strong>Conclusions: </strong>Cutaneous manifestations associated with COVID-19 are frequent and can be classified as inflammatory and vascular. Among them, urticarial lesions occupy the fourth place, and although there could be some predominance of these in patients with a history of allergies, more studies are required to define an association.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"68 3","pages":"214-217"},"PeriodicalIF":0.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista alergia Mexico","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29262/ram.v68i3.869","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: In December 2019, a new coronavirus was identified as the causal agent of the 2019 coronavirus disease (COVID-19) with a wide clinical spectrum that goes from asymptomatic cases to critical and fatal cases. Its usual manifestations are fever, cough, and fatigue; although some cases present skin lesions.

Cases report: The first case was a 30-year-old woman with a history of controlled solar urticaria who presented erythematous and pruritic wheals in malar and cervical regions and extremities; associated with general malaise, headaches, and nausea, in whom the presence of COVID-19 was confirmed; her condition improved with a quadruple dose of antihistamines. The second case was a 47-year-old woman with a history of wasp sting anaphylaxis, without mastocytosis, who presented nasal congestion, headaches, and hypogeusia associated with generalized, erythematous, and pruritic wheals, with confirmation of COVID-19; her condition improved with quadruple doses of antihistamines.

Conclusions: Cutaneous manifestations associated with COVID-19 are frequent and can be classified as inflammatory and vascular. Among them, urticarial lesions occupy the fourth place, and although there could be some predominance of these in patients with a history of allergies, more studies are required to define an association.

过敏患者与COVID-19相关的荨麻疹。一个案例系列]。
2019年12月,一种新的冠状病毒被确定为2019冠状病毒病(COVID-19)的病原体,其临床范围很广,从无症状病例到危重和致命病例。通常表现为发热、咳嗽和疲劳;虽然有些病例出现皮肤损伤。病例报告:第一位病例为30岁女性,有控制性日光性荨麻疹病史,在颈部和四肢出现红斑和瘙痒性皮疹;伴有全身不适、头痛和恶心,并已确认存在COVID-19;服用了四倍剂量的抗组胺药后,她的病情有所好转。第二个病例是一名47岁女性,有黄蜂蜇伤过敏史,无肥大细胞增多症,出现鼻塞、头痛和缺氧,伴有全身、红斑和瘙痒性皮疹,确诊为COVID-19;服用四倍剂量的抗组胺药后,她的病情有所好转。结论:与COVID-19相关的皮肤表现较为常见,可分为炎症性和血管性。其中,荨麻疹病变占第4位,虽然在有过敏史的患者中可能有一些优势,但需要更多的研究来确定两者之间的联系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Revista alergia Mexico
Revista alergia Mexico Medicine-Immunology and Allergy
CiteScore
0.70
自引率
0.00%
发文量
9
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书